Policy changes Backwork has recorded, newest first. The most recent change on record is from October 14, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
83,427 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Intensity-Modulated Radiotherapy (IMRT): Cancer of the Head and Neck or Thyroid | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Intensity-Modulated Radiotherapy (IMRT): Breast and Lung | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Intensity-Modulated Radiotherapy (IMRT): Abdomen, Pelvis and Chest | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Insulins (Non-Long Acting Products) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Injectable Oncology | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Injectable Bulking Agents for the Treatment of Urinary and Fecal Incontinence | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Inhaled Nitric Oxide | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Inhaled Antibiotics for Cystic Fibrosis | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Ingestible pH and Pressure Capsule | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Influenza Vaccine | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | In Vitro Chemoresistance and Chemosensitivity Assays | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Implantation of Intrastromal Corneal Ring Segments | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Implantable Peripheral Nerve Stimulation for Chronic Pain Conditions | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Implantable Infusion Pump | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Implantable Cardioverter Defibrillator | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Implantable Bone-Conduction and Bone-Anchored Hearing Aids | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Impavido (miltefosine) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Immunohistochemistry for Microscopic Evaluation of Prostate Biopsy | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Immunohistochemistry for Microscopic Evaluation of Breast Cancer | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Immunoglobulin Therapy | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Immune Thrombocytopenia | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Immune Cell Function Assay | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Image-Guided Minimally Invasive Decompression for Spinal Stenosis | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Igalmi (dexmedetomidine) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Identification of Microorganisms Using Nucleic Acid Probes | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Hyperthermic Intraperitoneal Chemotherapy for Select Intra-Abdominal and Pelvic Malignancies | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Hyperthermia Therapy | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Hyperbaric Oxygen Therapy | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Hydrogel Spacer Use During Radiotherapy for Prostate Cancer | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Human Growth Hormone and Insulin-like Growth Factor-1 | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Human Chorionic Gonadotropin | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Hormone Pellet Implantation for Hormone Replacement Therapy (HRT) in Women | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Homocysteine Testing in the Screening, Diagnosis, and Management of Cardiovascular Disease and Venous Thromboembolic Disease | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Home Uterine Activity Monitoring (HUAM) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Home Prothrombin Time Monitoring | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Home Non-Invasive Positive Airway Pressure Devices for the Treatment of Respiratory Insufficiency and Failure | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Home Cervical Traction Devices | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Home Cardiorespiratory Monitoring | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Hippotherapy | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Hip Resurfacing | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | High-Dose Rate Temporary Prostate Brachytherapy | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | High Sensitivity C-Reactive Protein (CRP) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | High Intensity Laser Therapy for Chronic Musculoskeletal Pain Conditions and Bell's Palsy | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Hidradenitis Suppurativa (HS) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Hereditary Angioedema (HAE) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Hemophilia Therapies | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Hematopoietic Stem-Cell Transplantation for Breast Cancer | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Hematopoietic Cell Transplantation in the Treatment of Germ Cell Tumors | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Hematopoietic Cell Transplantation for Solid Tumors of Childhood | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Hematopoietic Cell Transplantation for Primary Amyloidosis or Waldenstrom's Macroglobulinemia | New policy |